Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Synatura in Chronic Bronchitis Type COPD
NCT03623282Phase 4Completed
- Sponsor
- Ahn-Gook Pharmaceutical Co., Ltd.
- Start
- Apr 2017
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Synatura in chronic obstructive pulmonary disease (COPD), chronic bronchitis (CB), sponsored by Ahn-Gook Pharmaceutical Co., Ltd.. Started Apr 2017; status: completed.
02
Drugs
Synatura
03
Conditions
chronic obstructive pulmonary disease (COPD)chronic bronchitis (CB)
Beyond the preview
Go deeper on NCT03623282.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03623282.